Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib vs Hydrocodone/Acetaminophen in Postoperative Arthroscopic Pain
NCT00390260Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2002
- Primary completion
- Feb 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rofecoxib in postoperative pain, sponsored by Merck & Co.. Started Feb 2002; status: completed.
02
Drugs
rofecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00390260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390260.